Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
5
×
life sciences
national blog main
national top stories
san diego blog main
san diego top stories
5
×
san francisco blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
boston top stories
deals
gilead sciences
indiana blog main
indiana top stories
novartis
pfizer
adverum biotechnologies
alzheimer's disease
amgen
astrazeneca
biogen
cancer
cancer immunotherapy
What
ceo
5
×
bio
roundup
acquisitions
drug
biggest
crispr
daniel
gilead
moves
o’day
sciences
week
albert
announced
athena
big
biotech
bosley's
bosley’s
bourla
bridge
bucks
build
buy
cancer
cas
chief
collabs
company
company’s
countouriotis
covid
crime
deal
debut
departure
dyne’s
editas
exit
Language
unset
unknown
Current search:
biotech
×
ceo
×
" san diego top stories "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push